UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan
· Delayed Price · Currency is TWD 65.50
+0.10 (0.15%)
May 9, 2025, 1:15 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 3.97 billion as of May 9, 2025. Its market cap has decreased by -17.39% in one year.
Market Cap
3.97B
Enterprise Value
3.49B
Revenue
31.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.50
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 3.97B, an increase of 129.75%. That is a compound annual growth rate of 20.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.97B | -0.49% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | 1.62B | -6.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 167.19B |
| Caliway Biopharmaceuticals | 108.54B |
| Bora Pharmaceuticals Co., LTD. | 71.99B |
| Lotus Pharmaceutical | 58.99B |
| Polaris Group | 33.89B |
| Oneness Biotech | 27.45B |
| Pegavision | 26.68B |
| Sunmax Biotechnology | 26.61B |